drug

Cobalamin

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
NCT03790345Phase 2, Phase 3Unknown

KOLs & investigators

1
Lia LO Sanders, MD, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara
company
trial
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
PHASE2, PHASE3
trial
indication
Schizophrenia
indication
Oxidative Stress
indication
Drug Induced Movement Disorder, Unspecified
indication
Schizophrenia
indication
KOL
Lia LO Sanders, MD, PhD
KOL score —
person